12:03 - 12:51
Tre-O1
Treatments | Oral presentations 1
Chair/s:
Ulrike Wehkamp, Evangelina Papadavid, Chalid Assaf
12:03 - 12:15
Tre-O1-01
Characteristics, Management and Course of Mycosis Fungoides in Solid Organ Transplant Recipients: A Retrospective Cohort from Two Cutaneous Lymphoma Outpatient Clinics
Oral presentation
Iris Amitay-Laish
(Division of Dermatology, Rabin Medical Center – Beilinson Hospital, Petah Tikva, Israel | Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel)
 
12:15 - 12:27
Tre-O1-02
Real world data shows that Chlormethine gel is efficient and safe in mycosis fungoides skin lesions
Oral presentation
Marios Koumourtzis
(2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Athens, Greece | Department of Dermatology and Venereology, University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece | 2nd Dermatology Department, Aristotle University, Faculty of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece | Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece)
 
12:27 - 12:39
Tre-O1-03
Response to Brentuximab vedotin in advanced stage MF/Sézary syndrome with low CD-30 expression - "Real-life" Data of the German Cutaneous Lymphoma Network
Oral presentation
Christoph Blazejak
(Department of Dermatology HELIOS Klinikum Krefeld, Krefeld, Germany)
 
12:39 - 12:51
Tre-O1-04
Assessment of skin involvement in cutaneous T-cell lymphoma using convolutional neural networks
Oral presentation
Christina J Walker
(Department of Dermatology, University Hospital Kiel, Kiel, Germany)